Alcon Pharmaceuticals Ltd v. Lupin Ltd.

1:12-cv-00973

Overview

Case Number 1:12-cv-00973

Filing Date 2012-07-24

Status Terminated

Termination Date 2013-12-03

Court District Court, D. Delaware (ded)

Presiding Judge Sue L. Robinson

Nature of Suit 830 Patent

Jurisdiction Type Federal Question

Cause of Action 35:271 Patent Infringement

Jury Demand None

Parties

Plaintiff

Alcon Pharmaceuticals Ltd

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Alcon Research Ltd.

Represented By

2 Attorneys Listed

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Rodger Dallery Smith , II

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9205

1201 North Market Street, P.O. Box 1347

Counter Claimant

Lupin Ltd.

Represented By

1 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Lupin Pharmaceuticals Inc.

Represented By

1 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Court & Judges

Court

District Court, D. Delaware (ded)

Presiding Judge

Sue L. Robinson

Patents Involved

2 Patents

There are 2 patents involved in this case.

Application Number	Patent Number	External Links
-	US6716830	Espacenet Google Patents
-	US7671070	Espacenet Google Patents

Docket Entries

COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1110781.) - filed by Alcon Research Ltd., Alcon Pharmaceuticals Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dzb, ) (Entered: 07/24/2012)

2012-07-24

Download

COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1110781.) - filed by Alcon Research Ltd., Alcon Pharmaceuticals Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dzb, ) (Entered: 07/24/2012)

2012-07-24

View

COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1110781.) - filed by Alcon Research Ltd., Alcon Pharmaceuticals Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dzb, ) (Entered: 07/24/2012)

2012-07-24

View

COMPLAINT filed against Lupin Ltd., Lupin Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1110781.) - filed by Alcon Research Ltd., Alcon Pharmaceuticals Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(dzb, ) (Entered: 07/24/2012)

2012-07-24

View

Alcon Pharmaceuticals Ltd v. Lupin Ltd.

Overview

Parties

Plaintiff

Alcon Pharmaceuticals Ltd

Represented By

Alcon Research Ltd.

Represented By

Counter Claimant

Lupin Ltd.

Represented By

Lupin Pharmaceuticals Inc.

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dzb, ) Modified on 7/24/2012 (dzb, ). (Entered: 07/24/2012)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/25/2012. Date of Expiration of Patent: 3/29/2020.Thirty Month Stay Deadline: 12/25/2014. (dzb, ) (Entered: 07/24/2012)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,716,830 B2; 7,671,070 B2;. (dzb, ) (Entered: 07/24/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Alcon Pharmaceuticals Ltd, Alcon Research Ltd. identifying Corporate Parent Novartis AG for Alcon Pharmaceuticals Ltd, Alcon Research Ltd.. (dzb, ) (Entered: 07/24/2012)

STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to September 24, 2012 - filed by Alcon Pharmaceuticals Ltd, Alcon Research Ltd., Lupin Ltd., Lupin Pharmaceuticals Inc.. (Phillips, John) (Entered: 08/01/2012)

MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Adam L. Perlman, David I. Berl, Scott K. Dasovich and Daniel P. Pierce of WILLIAM & CONNOLLY LLP - filed by Alcon Pharmaceuticals Ltd, Alcon Research Ltd.. (Smith, Rodger) (Entered: 08/15/2012)

Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 9/28/2012 at 09:00 AM before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 9/5/2012. Associated Cases: 1:11-cv-00587-SLR-CJB, 1:12-cv-00960-SLR, 1:12-cv-00973-SLR(nmfn) (Entered: 09/05/2012)

ANSWER to 1 Complaint, Lupin's Answer, Affirmative Defenses and, COUNTERCLAIM against Alcon Pharmaceuticals Ltd, Alcon Research Ltd. by Lupin Pharmaceuticals Inc., Lupin Ltd..(Phillips, John) (Entered: 09/24/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Lupin Ltd., Lupin Pharmaceuticals Inc. identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals Inc... (Phillips, John) (Entered: 09/24/2012)

PROPOSED ORDER -- SCHEDULING ORDER -- by Alcon Pharmaceuticals Ltd, Alcon Research Ltd.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson from Rodger D. Smith II enclosing Scheduling Order)(Smith, Rodger) (Entered: 09/27/2012)

PROPOSED ORDER -- SCHEDULING ORDER -- by Alcon Pharmaceuticals Ltd, Alcon Research Ltd.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson from Jack B. Blumenfeld enclosing scheduling order)(Blumenfeld, Jack) (Entered: 10/03/2012)

Case associated with lead case: Create association to 1:11-cv-00587-SLR. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 11-587-SLR. (nmfn)

CASES CLOSED per D.I. 181 in Lead Case No. 11-cv-587-SLR. Associated Cases: 1:11-cv-00587-SLR, 1:12-cv-00960-SLR, 1:12-cv-00973-SLR(nmfn)

Alcon Pharmaceuticals Ltd v. Lupin Ltd.

Overview

Parties

Plaintiff

Alcon Pharmaceuticals Ltd Follow

Represented By

Alcon Research Ltd. Follow

Represented By

Counter Claimant

Lupin Ltd. Follow

Represented By

Lupin Pharmaceuticals Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dzb, ) Modified on 7/24/2012 (dzb, ). (Entered: 07/24/2012)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/25/2012. Date of Expiration of Patent: 3/29/2020.Thirty Month Stay Deadline: 12/25/2014. (dzb, ) (Entered: 07/24/2012)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,716,830 B2; 7,671,070 B2;. (dzb, ) (Entered: 07/24/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Alcon Pharmaceuticals Ltd, Alcon Research Ltd. identifying Corporate Parent Novartis AG for Alcon Pharmaceuticals Ltd, Alcon Research Ltd.. (dzb, ) (Entered: 07/24/2012)

STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to Complaint to September 24, 2012 - filed by Alcon Pharmaceuticals Ltd, Alcon Research Ltd., Lupin Ltd., Lupin Pharmaceuticals Inc.. (Phillips, John) (Entered: 08/01/2012)

MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Adam L. Perlman, David I. Berl, Scott K. Dasovich and Daniel P. Pierce of WILLIAM & CONNOLLY LLP - filed by Alcon Pharmaceuticals Ltd, Alcon Research Ltd.. (Smith, Rodger) (Entered: 08/15/2012)

Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 9/28/2012 at 09:00 AM before Judge Sue L. Robinson. Signed by Judge Sue L. Robinson on 9/5/2012. Associated Cases: 1:11-cv-00587-SLR-CJB, 1:12-cv-00960-SLR, 1:12-cv-00973-SLR(nmfn) (Entered: 09/05/2012)

ANSWER to 1 Complaint, Lupin's Answer, Affirmative Defenses and, COUNTERCLAIM against Alcon Pharmaceuticals Ltd, Alcon Research Ltd. by Lupin Pharmaceuticals Inc., Lupin Ltd..(Phillips, John) (Entered: 09/24/2012)

Disclosure Statement pursuant to Rule 7.1 filed by Lupin Ltd., Lupin Pharmaceuticals Inc. identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals Inc... (Phillips, John) (Entered: 09/24/2012)

PROPOSED ORDER -- SCHEDULING ORDER -- by Alcon Pharmaceuticals Ltd, Alcon Research Ltd.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson from Rodger D. Smith II enclosing Scheduling Order)(Smith, Rodger) (Entered: 09/27/2012)

PROPOSED ORDER -- SCHEDULING ORDER -- by Alcon Pharmaceuticals Ltd, Alcon Research Ltd.. (Attachments: # 1 Letter to The Honorable Sue L. Robinson from Jack B. Blumenfeld enclosing scheduling order)(Blumenfeld, Jack) (Entered: 10/03/2012)

Case associated with lead case: Create association to 1:11-cv-00587-SLR. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 11-587-SLR. (nmfn)

CASES CLOSED per D.I. 181 in Lead Case No. 11-cv-587-SLR. Associated Cases: 1:11-cv-00587-SLR, 1:12-cv-00960-SLR, 1:12-cv-00973-SLR(nmfn)

Track Case Updates

Alcon Pharmaceuticals Ltd

Alcon Research Ltd.

Lupin Ltd.

Lupin Pharmaceuticals Inc.